Indication

Complicated UTI with Pseudomonas aeruginosa

A complicated urinary tract infection with *Pseudomonas aeruginosa* is an infection of the upper or lower urinary tract occurring in individuals with predisposing factors such as structural abnormalities, urinary tract obstruction, indwelling catheters, instrumentation, or systemic immunocompromise. Read more about Complicated UTI with Pseudomonas aeruginosa

77 drugs 46 manufacturers

Advertisement

Drugs that treat it

Common Complicated UTI with Pseudomonas aeruginosa therapies.

Showing 19–27 of 77 drugs

CEFTAZIDIME

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
SAGENT PHARMACE

CEFTAZIDIME

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
WG CRITICAL CAR
Filter & compare in the drug finder →Opens the drug finder with Complicated UTI with Pseudomonas aeruginosa preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complicated UTI with Pseudomonas aeruginosa.

A complicated urinary tract infection with *Pseudomonas aeruginosa* is an infection of the upper or lower urinary tract occurring in individuals with predisposing factors such as structural abnormalities, urinary tract obstruction, indwelling catheters, instrumentation, or systemic immunocompromise.

Pathophysiologically, the condition is driven by the opportunistic, Gram-negative bacillus *Pseudomonas aeruginosa*, which utilizes virulence mechanisms including biofilm formation, motility, and intrinsic or acquired resistance mechanisms to colonize altered urothelium and implanted devices.

Patients frequently present with typical lower urinary tract symptoms, fever, flank pain, or signs of urosepsis, and they face a heightened risk of treatment failure, tissue invasion, and recurrent disease.

Personalize your experience

Follow Complicated UTI with Pseudomonas aeruginosa and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it